Asian equity markets ended mostly in red on Thursday, with Japanese shares coming under heavy selling pressure, as the yen continued to surge and shares of drug makers dropped following Trump's comments on drug pricing. Trump brief failed to offer more clarity around his stimulus plans and trade policies at the news conference, disappointing some investors who had hoped for more details on his plans to cut taxes and reduce regulation. Further, Chinese shares ended lower as investors moved to the sidelines ahead of the Lunar New Year holidays starting on Jan 27.
Asian Indices | Last Trade | Change in Points | Change in % |
Shanghai Composite | 3,119.29 | -17.46 | -0.56 |
Hang Seng | 22,829.02 | -106.33 | -0.46 |
Jakarta Composite | 5,292.75 | -8.49 | -0.16 |
KLSE Composite | 1,679.28 | 4.07 | 0.24 |
Nikkei 225 | 19,134.70 | -229.97 | -1.19 |
Straits Times | 2,992.30 | -8.64 | -0.29 |
KOSPI Composite | 2,087.14 | 11.97 | 0.58 |
Taiwan Weighted | 9,410.18 | 64.44 | 0.69 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: